Steven Cohen Milestone Pharmaceuticals Inc. Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.85 - $4.4 $2.97 Million - $4.59 Million	-1,042,341 Reduced 81.75%	232,659 $663,000
Q1 2023 May 15, 2023	BUY	$3.14 - $4.2 $1.26 Million - $1.68 Million	400,000 Added 45.71%	1,275,000 $5.02 Million
Q4 2022 Feb 14, 2023	BUY	$3.53 - $9.5 $3.09 Million - $8.31 Million	875,000 New	875,000 $3.47 Million

25.1M

61.2K

38.8K

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $57M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.